ImmunoTherapy | Financial Buzz

Tag: ImmunoTherapy

post-image
Biotechnology Breaking News Healthcare Market News Technology The Market Buzz

Breaking News: Kalos Therapeutics, Inc., Oncology Pharmaceuticals and NanoSmart Pharmaceuticals, Inc., Combination Therapy Offers the Potential of a Safer and More Effective Approach to a Wide Variety of Cancer Treatments

Author financial buzzPosted on
3617
1
Oncology Pharma (OTC: ONPH) is pleased to announce that Kalos Therapeutics’ lead compound, KTH-222, can produce a reduction in the attachment of newly seeded cells to a solid-phase by...
post-image
Biotechnology Breaking News Healthcare Market News Technology The Market Buzz

Breaking News: Oncology Pharma Signed a Letter of Intent with Kalos Therapeutics for an Exclusive World-Wide License and Co-Development of Its Broad-Spectrum Anti-Cancer Drug, KTH 222

Author financial buzzPosted on
5706
2
Oncology Pharma (OTC: ONPH) is pleased to announce that it signed a Letter of Intent with Kalos Therapeutics (Phoenix, AZ) for a world-wide license and co-development of Kalos’s lead...